WESTBROOK, ME (August 20, 2021) – Lab operations, particularly those in the cell and gene therapy space, are utilizing automation to cope with quality requirements in the face of limited resources. Artel is partnering with the Cambridge Healthtech Institute in presenting a webinar titled “Managing Quality and Compliance Operations in an Accelerating Scientific Landscape” in response to these requirements. This Executive Webinar will be held on September 22, 2021, from 11:00 to 12:00 EDT, and brings together experienced thought leaders to share and discuss insights on quality topics critical to success. The presenters are Kay McDonald, the senior director of Quality Control at Generation Bio, and Nathaniel Hentz, director of Scientific Market Development at Artel.
Topics for discussion will include:
These topics will be broken down into four key elements comprising (1) managing outsourcing while maintaining the highest quality and compliance, (2) integrating the different mindsets from R&D to quality and compliance, (3) assuring quality and compliance with limited resources, and (4) making cost-effective choices when investing in automation for the quality operation.
We invite you to join the conversation by registering for the webinar here. If, before or after, you would like to discuss the topics in more detail, please feel free to contact Dr. Hentz at [email protected].